Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
ORTHOPAEDICS	O
Allergies:	O
Ibuprofen	O
/	O
Iodine	O
Containing	O
Agents	O
Classifier	O
/	O
fiberglass	O
Attending:	O
___	O
Chief	O
Complaint:	O
Right	O
knee	O
pain	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
___	O
R	O
total	O
knee	O
replacement	O
History	O
of	O
Present	O
Illness:	O
___	O
y/o	O
F	O
with	O
progressive	O
R	O
knee	O
osteoarthritis	O
Past	O
Medical	O
History:	O
OSA,	O
Obesity,	O
GERD,	O
Social	O
History:	O
___	O
Family	O
History:	O
Non-contributory	O
Physical	O
Exam:	O
Well	O
appearing	O
in	O
no	O
acute	O
distress	O
Afebrile	O
with	O
stable	O
vital	O
signs	O
Pain	O
well-controlled	O
Respiratory:	O
CTAB	O
Cardiovascular:	O
RRR	O
Gastrointestinal:	O
NT/ND	O
Genitourinary:	O
Voiding	O
independently	O
Neurologic:	O
Intact	O
with	O
no	O
focal	O
deficits	O
Psychiatric:	O
Pleasant,	O
A&O	B-Delirium
x3	B-Delirium
Musculoskeletal	O
Lower	O
Extremity:	O
*	O
Incision	O
healing	O
well	O
with	O
staples	O
*	O
Scant	O
serosanguinous	O
drainage	O
*	O
Thigh	O
full	O
but	O
soft	O
*	O
No	O
calf	O
tenderness	O
*	O
___	O
strength	O
*	O
SILT,	O
NVI	O
distally	O
*	O
Toes	O
warm	O
Pertinent	O
Results:	O
___	O
06:00AM	O
BLOOD	O
WBC-11.9*	O
RBC-3.96*	O
Hgb-12.1	O
Hct-35.4*	O
MCV-89	O
MCH-30.5	O
MCHC-34.2	O
RDW-13.3	O
Plt	O
___	O
___	O
06:50AM	O
BLOOD	O
WBC-12.3*	O
RBC-4.01*	O
Hgb-12.0	O
Hct-36.5	O
MCV-91	O
MCH-30.0	O
MCHC-33.0	O
RDW-13.4	O
Plt	O
___	O
___	O
07:40AM	O
BLOOD	O
WBC-12.5*	O
RBC-4.29	O
Hgb-12.7	O
Hct-39.2	O
MCV-91	O
MCH-29.7	O
MCHC-32.5	O
RDW-13.4	O
Plt	O
___	O
___	O
06:00AM	O
BLOOD	O
Plt	O
___	O
___	O
06:50AM	O
BLOOD	O
Plt	O
___	O
___	O
07:40AM	O
BLOOD	O
Plt	O
___	O
___	O
06:00AM	O
BLOOD	O
Glucose-106*	O
UreaN-11	O
Creat-0.7	O
Na-135	O
K-4.3	O
Cl-100	O
HCO3-26	O
AnGap-13	O
___	O
06:50AM	O
BLOOD	O
Glucose-104*	O
UreaN-9	O
Creat-0.7	O
Na-133	O
K-4.3	O
Cl-99	O
HCO3-23	O
AnGap-15	O
___	O
07:40AM	O
BLOOD	O
Glucose-126*	O
UreaN-18	O
Creat-0.9	O
Na-136	O
K-4.3	O
Cl-101	O
HCO3-26	O
AnGap-13	O
___	O
06:00AM	O
BLOOD	O
Calcium-8.4	O
Phos-1.8*	O
Mg-1.7	O
___	O
06:50AM	O
BLOOD	O
Phos-2.0*	O
Mg-1.8	O
___	O
07:40AM	O
BLOOD	O
Calcium-8.8	O
Phos-3.3	O
Mg-1.6	O
Brief	O
Hospital	O
Course:	O
The	O
patient	O
was	O
admitted	O
to	O
the	O
Orthopaedic	O
surgery	O
service	O
and	O
was	O
taken	O
to	O
the	O
operating	O
room	O
for	O
above	O
described	O
procedure.	O
Please	O
see	O
separately	O
dictated	O
operative	O
report	O
for	O
details.	O
The	O
surgery	O
was	O
uncomplicated	O
and	O
the	O
patient	O
tolerated	O
the	O
procedure	O
well.	O
Patient	O
received	O
perioperative	O
IV	O
antibiotics.	O
Postoperative	O
course	O
was	O
remarkable	O
for	O
the	O
following:	O
Patient	O
noted	O
that	O
that	O
she	O
had	O
a	O
chipped	O
tooth	O
after	O
anesthesia.	O
Anesthesia	O
notified	O
and	O
incident	O
report	O
filed	O
Patient	O
failed	O
to	O
void	O
during	O
first	O
void	O
trial	O
on	O
POD	O
#2,	O
the	O
foley	O
was	O
replaced	O
and	O
patient	O
voided	O
independently.	O
Otherwise,	O
pain	O
was	O
initially	O
controlled	O
with	O
a	O
PCA	O
followed	O
by	O
a	O
transition	O
to	O
oral	O
pain	O
medications	O
on	O
POD#1.	O
The	O
patient	O
received	O
Lovenox	O
for	O
DVT	O
prophylaxis	O
starting	O
on	O
the	O
morning	O
of	O
POD#1.	O
The	O
foley	O
was	O
removed	O
on	O
POD	O
#2	O
and	O
#3	O
and	O
the	O
patient	O
was	O
voiding	O
independently	O
thereafter.	O
The	O
overlying	O
dressing	O
was	O
removed	O
on	O
POD#2	O
and	O
the	O
Silverlon	O
dressing	O
was	O
found	O
to	O
be	O
clean	O
and	O
dry.	O
The	O
patient	O
was	O
seen	O
daily	O
by	O
physical	O
therapy.	O
Labs	O
were	O
checked	O
throughout	O
the	O
hospital	O
course	O
and	O
repleted	O
accordingly.	O
At	O
the	O
time	O
of	O
discharge	O
the	O
patient	O
was	O
tolerating	O
a	O
regular	O
diet	O
and	O
feeling	O
well.	O
The	O
patient	O
was	O
afebrile	O
with	O
stable	O
vital	O
signs.	O
The	O
patient's	O
hematocrit	O
was	O
acceptable	O
and	O
pain	O
was	O
adequately	O
controlled	O
on	O
an	O
oral	O
regimen.	O
The	O
operative	O
extremity	O
was	O
neurovascularly	O
intact	O
and	O
the	O
wound	O
was	O
benign.	O
The	O
patient's	O
weight-bearing	O
status	O
is	O
weight	O
bearing	O
as	O
tolerated	O
on	O
the	O
operative	O
extremity.	O
Please	O
use	O
walker	B-Mobile_with_aid
or	B-Mobile_with_aid
2	B-Mobile_with_aid
crutches	B-Mobile_with_aid
at	O
all	O
times	O
for	O
6	O
weeks.	O
Ms.	O
___	O
is	O
discharged	O
to	O
rehab	O
in	O
stable	O
condition.	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
amlodipine-benazepril	O
___	O
mg	O
oral	O
daily	O
2.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
3.	O
CeleBREX	O
(celecoxib)	O
200	O
mg	O
oral	O
bid	O
4.	O
Ezetimibe	O
10	O
mg	O
PO	O
DAILY	O
5.	O
fenofibrate	O
120	O
mg	O
oral	O
daily	O
6.	O
Loratadine	O
10	O
mg	O
PO	O
DAILY	O
7.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
8.	O
Alendronate	O
Sodium	O
70	O
mg	O
PO	O
QSAT	O
9.	O
mirabegron	O
25	O
mg	O
oral	O
daily	O
*AST	O
Approval	O
Required*	O
10.	O
ValACYclovir	O
500	O
mg	O
PO	O
Q24H	O
11.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
12.	O
Magnesium	O
Oxide	O
400	O
mg	O
PO	O
DAILY	O
13.	O
Psyllium	O
1	O
PKT	O
PO	O
TID:PRN	O
constipation	B-Constipation
14.	O
Simvastatin	O
40	O
mg	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
2.	O
Ezetimibe	O
10	O
mg	O
PO	O
DAILY	O
3.	O
fenofibrate	O
120	O
mg	O
oral	O
daily	O
4.	O
Loratadine	O
10	O
mg	O
PO	O
DAILY	O
5.	O
mirabegron	O
25	O
mg	O
oral	O
daily	O
6.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
7.	O
Psyllium	O
1	O
PKT	O
PO	O
TID:PRN	O
constipation	B-Constipation
8.	O
Simvastatin	O
40	O
mg	O
PO	O
DAILY	O
9.	O
ValACYclovir	O
500	O
mg	O
PO	O
Q24H	O
10.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
11.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q6H	O
12.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
13.	O
Sarna	O
Lotion	O
1	O
Appl	O
TP	O
TID:PRN	O
pruritis	O
14.	O
Senna	O
8.6	O
mg	O
PO	O
BID	O
15.	O
amlodipine-benazepril	O
___	O
mg	O
ORAL	O
DAILY	O
16.	O
Magnesium	O
Oxide	O
400	O
mg	O
PO	O
DAILY	O
17.	O
Alendronate	O
Sodium	O
70	O
mg	O
PO	O
QSAT	O
18.	O
Enoxaparin	O
Sodium	O
40	O
mg	O
SC	O
DAILY	O
Duration:	O
28	O
Doses	O
Start:	O
___,	O
First	O
Dose:	O
Next	O
Routine	O
Administration	O
Time	O
19.	O
HYDROmorphone	O
(Dilaudid)	O
___	O
mg	O
PO	O
Q3H:PRN	O
pain	O
RX	O
*hydromorphone	O
2	O
mg	O
___	O
tablet(s)	O
by	O
mouth	O
q3h	O
Disp	O
#*70	O
Tablet	O
Refills:*0	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Right	O
knee	O
arthritis	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	B-Mobile_with_assistance
requires	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
1.	O
Please	O
return	O
to	O
the	O
emergency	O
department	O
or	O
notify	O
your	O
physician	O
if	O
you	O
experience	O
any	O
of	O
the	O
following:	O
severe	O
pain	O
not	O
relieved	O
by	O
medication,	O
increased	O
swelling,	O
decreased	O
sensation,	O
difficulty	O
with	O
movement,	O
fevers	O
greater	O
than	O
101.5,	O
shaking	O
chills,	O
increasing	O
redness	O
or	O
drainage	O
from	O
the	O
incision	O
site,	O
chest	O
pain,	O
shortness	O
of	O
breath	O
or	O
any	O
other	O
concerns.	O
2.	O
Please	O
follow	O
up	O
with	O
your	O
primary	O
physician	O
regarding	O
this	O
admission	O
and	O
any	O
new	O
medications	O
and	O
refills.	O
3.	O
Resume	O
your	O
home	O
medications	O
unless	O
otherwise	O
instructed.	O
4.	O
You	O
have	O
been	O
given	O
medications	O
for	O
pain	O
control.	O
Please	O
do	O
not	O
drive,	O
operate	O
heavy	O
machinery,	O
or	O
drink	O
alcohol	O
while	O
taking	O
these	O
medications.	O
As	O
your	O
pain	O
decreases,	O
take	O
fewer	O
tablets	O
and	O
increase	O
the	O
time	O
between	O
doses.	O
This	O
medication	O
can	O
cause	O
constipation,	B-Constipation
so	O
you	O
should	O
drink	O
plenty	O
of	O
water	O
daily	O
and	O
take	O
a	O
stool	O
softener	O
(such	O
as	O
Colace)	O
as	O
needed	O
to	O
prevent	O
this	O
side	O
effect.	O
Call	O
your	O
surgeons	O
office	O
3	O
days	O
before	O
you	O
are	O
out	O
of	O
medication	O
so	O
that	O
it	O
can	O
be	O
refilled.	O
These	O
medications	O
cannot	O
be	O
called	O
into	O
your	O
pharmacy	O
and	O
must	O
be	O
picked	O
up	O
in	O
the	O
clinic	O
or	O
mailed	O
to	O
your	O
house.	O
Please	O
allow	O
an	O
extra	O
2	O
days	O
if	O
you	O
would	O
like	O
your	O
medication	O
mailed	O
to	O
your	O
home.	O
5.	O
You	O
may	O
not	O
drive	O
a	O
car	O
until	O
cleared	O
to	O
do	O
so	O
by	O
your	O
surgeon.	O
6.	O
Please	O
call	O
your	O
surgeon's	O
office	O
to	O
schedule	O
or	O
confirm	O
your	O
follow-up	O
appointment.	O
7.	O
SWELLING:	O
Ice	O
the	O
operative	O
joint	O
20	O
minutes	O
at	O
a	O
time,	O
especially	O
after	O
activity	O
or	O
physical	O
therapy.	O
Do	O
not	O
place	O
ice	O
directly	O
on	O
the	O
skin.	O
You	O
may	O
wrap	O
the	O
knee	O
with	O
an	O
ace	O
bandage	O
for	O
added	O
compression.	O
Please	O
DO	O
NOT	O
take	O
any	O
non-steroidal	O
anti-inflammatory	O
medications	O
(NSAIDs	O
such	O
as	O
Celebrex,	O
ibuprofen,	O
Advil,	O
Aleve,	O
Motrin,	O
naproxen	O
etc).	O
8.	O
ANTICOAGULATION:	O
Please	O
continue	O
your	O
Lovenox	O
for	O
four	O
(4)	O
weeks	O
to	O
help	O
prevent	O
deep	O
vein	O
thrombosis	O
(blood	O
clots).	O
If	O
you	O
were	O
taking	O
aspirin	O
prior	O
to	O
your	O
surgery,	O
it	O
is	O
OK	O
to	O
continue	O
at	O
your	O
previous	O
dose	O
while	O
taking	O
anticoagulation	O
medication.	O
___	O
STOCKINGS	O
x	O
6	O
WEEKS.	O
9.	O
WOUND	O
CARE:	O
Please	O
keep	O
your	O
Silverlon	O
dressing	O
clean	O
and	O
dry.	O
Remove	O
on	O
___.	O
It	O
is	O
okay	O
to	O
shower	O
five	O
days	O
after	O
surgery	O
but	O
no	O
tub	O
baths,	O
swimming,	O
or	O
submerging	O
your	O
incision	O
until	O
after	O
your	O
four	O
(4)	O
week	O
checkup.	O
You	O
may	O
place	O
a	O
dry	O
sterile	O
dressing	O
on	O
the	O
wound	O
after	O
the	O
Silverlon	O
dressing	O
is	O
removed,	O
otherwise	O
leave	O
it	O
open	O
to	O
air.	O
Check	O
wound	O
regularly	O
for	O
signs	O
of	O
infection	O
such	O
as	O
redness	O
or	O
thick	O
yellow	O
drainage.	O
Staples	O
will	O
be	O
removed	O
by	O
the	O
visiting	O
nurse	O
or	O
rehab	O
facility	O
in	O
two	O
(2)	O
weeks.	O
10.	O
___	O
(once	O
at	O
home):	O
Home	O
___,	O
dressing	O
changes	O
as	O
instructed,	O
wound	O
checks,	O
and	O
staple	O
removal	O
at	O
two	O
weeks	O
after	O
surgery.	O
11.	O
ACTIVITY:	O
Weight	O
bearing	O
as	O
tolerated	O
on	O
the	O
operative	O
extremity.	O
Two	O
crutches	B-Mobile_with_aid
or	B-Mobile_with_aid
walker	B-Mobile_with_aid
at	O
all	O
times	O
for	O
6	O
weeks.	O
Mobilize.	O
CPM/ROM	O
as	O
tolerated.	O
No	O
strenuous	O
exercise	O
or	O
heavy	O
lifting	O
until	O
follow	O
up	O
appointment.	O
Physical	O
Therapy:	O
ACTIVITY:	O
Weight	O
bearing	O
as	O
tolerated	O
on	O
the	O
operative	O
extremity.	O
Two	O
crutches	B-Mobile_with_aid
or	B-Mobile_with_aid
walker	B-Mobile_with_aid
at	O
all	O
times	O
for	O
6	O
weeks.	O
Mobilize.	O
CPM/ROM	O
as	O
tolerated.	O
No	O
strenuous	O
exercise	O
or	O
heavy	O
lifting	O
until	O
follow	O
up	O
appointment.	O
Treatments	O
Frequency:	O
WOUND	O
CARE:	O
Please	O
keep	O
your	O
Silverlon	O
dressing	O
clean	O
and	O
dry.	O
Remove	O
on	O
___.	O
It	O
is	O
okay	O
to	O
shower	O
five	O
days	O
after	O
surgery	O
but	O
no	O
tub	O
baths,	O
swimming,	O
or	O
submerging	O
your	O
incision	O
until	O
after	O
your	O
four	O
(4)	O
week	O
checkup.	O
You	O
may	O
place	O
a	O
dry	O
sterile	O
dressing	O
on	O
the	O
wound	O
after	O
the	O
Silverlon	O
dressing	O
is	O
removed,	O
otherwise	O
leave	O
it	O
open	O
to	O
air.	O
Check	O
wound	O
regularly	O
for	O
signs	O
of	O
infection	O
such	O
as	O
redness	O
or	O
thick	O
yellow	O
drainage.	O
Staples	O
will	O
be	O
removed	O
by	O
the	O
visiting	O
nurse	O
or	O
rehab	O
facility	O
in	O
two	O
(2)	O
weeks.	O
___	O
(once	O
at	O
home):	O
Home	O
___,	O
dressing	O
changes	O
as	O
instructed,	O
wound	O
checks,	O
and	O
staple	O
removal	O
at	O
two	O
weeks	O
after	O
surgery.	O
ACTIVITY:	O
Weight	O
bearing	O
as	O
tolerated	O
on	O
the	O
operative	O
extremity.	O
Two	O
crutches	B-Mobile_with_aid
or	B-Mobile_with_aid
walker	B-Mobile_with_aid
at	O
all	O
times	O
for	O
6	O
weeks.	O
Mobilize.	O
CPM/ROM	O
as	O
tolerated.	O
No	O
strenuous	O
exercise	O
or	O
heavy	O
lifting	O
until	O
follow	O
up	O
appointment.	O
Followup	O
Instructions:	O
___	O

